Mayinglong Pharmaceutical Group Co Ltd600993
▲ PositiveRegulationrelevance
Two drugs newly included in National Essential Medicines List, likely boosting sales and market access.
Impact on stocks 1
Others
Mayinglong Pharmaceutical Group Co LtdMayinglong announced that two of its drugs have been newly included in the National Essential Medicines List (2026 Edition), namely Mayinglong Babao Eye Ointment and Tofacitinib. The list was recently released by the National Health Commission and other authorities. In the first quarter of 2026, Mayinglong achieved revenue of 1.012 billion yuan and net profit attributable to the parent company of 213 million yuan.
Mayinglong Pharmaceutical Group Co LtdTwo drugs newly included in National Essential Medicines List, likely boosting sales and market access.